TOFACITINIB citrate
(3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine2-hydroxy-1,2,3-propanetricarboxylate;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile2-Hydroxy-1,2,3-propanetricarboxylate;CP690500-10;CP690550-10;1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-,(3R,4R)-,citrate

Product Name: Tofacitinib citrate

 

Synonyms: (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine2-hydroxy-1,2,3-propanetricarboxylate;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile2-Hydroxy-1,2,3-propanetricarboxylate;CP690500-10;CP690550-10;1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-,(3R,4R)-,citrate

 

CAS:540737-29-9

 

MF: C16H20N6O.C6H8O7

 

MW: 504.497

 

Notice: If the compound is involved in patent protection, please do not use it for commercial purposes, and only for experimental analysis and research purposes. If it is sold to countries that constitute patent infringement, all the corresponding risks are not related to our company.